Literature DB >> 19211743

Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection.

Joseph N Blattman1, E John Wherry, Sang-Jun Ha, Robbert G van der Most, Rafi Ahmed.   

Abstract

During some persistent viral infections, virus-specific T-cell responses wane due to the antigen-specific deletion or functional inactivation (i.e., exhaustion) of responding CD8 T cells. T-cell exhaustion often correlates with high viral load and is associated with the expression of the inhibitory receptor PD-1. In other infections, functional T cells are observed despite high levels of pathogen persistence. The reasons for these different T-cell fates during chronic viral infections are not clear. Here, we tracked the fate of virus-specific CD8 T cells in lymphocytic choriomeningitis virus (LCMV)-infected mice during viral clearance, the persistence of wild-type virus, or the selection and persistence of a viral variant that abrogates the presentation of a single epitope. Viral clearance results in PD-1(lo) functional virus-specific CD8 T cells, while the persistence of wild-type LCMV results in high PD-1 levels and T-cell exhaustion. However, following the emergence of a GP35V-->A variant virus that abrogates the presentation of the GP33 epitope, GP33-specific CD8 T cells remained functional, continued to show low levels of PD-1, and reexpressed CD127, a marker of memory T-cell differentiation. In the same animals and under identical environmental conditions, CD8 T cells recognizing nonmutated viral epitopes became physically deleted or were PD-1(hi) and nonfunctional. Thus, the upregulation of PD-1 and the functional inactivation of virus-specific T cells during chronic viral infection is dependent upon continued epitope recognition. These data suggest that optimal strategies for vaccination should induce high-magnitude broadly specific T-cell responses that prevent cytotoxic T-lymphocyte escape and highlight the need to evaluate the function of vaccine-induced T cells in the context of antigens presented during virus persistence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211743      PMCID: PMC2668476          DOI: 10.1128/JVI.02524-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.

Authors:  N H Gruener; F Lechner; M C Jung; H Diepolder; T Gerlach; G Lauer; B Walker; J Sullivan; R Phillips; G R Pape; P Klenerman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Persistence of memory CD8 T cells in MHC class I-deficient mice.

Authors:  K Murali-Krishna; L L Lau; S Sambhara; F Lemonnier; J Altman; R Ahmed
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

3.  High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.

Authors:  S Kostense; G S Ogg; E H Manting; G Gillespie; J Joling; K Vandenberghe; E Z Veenhof; D van Baarle ; S Jurriaans; M R Klein; F Miedema
Journal:  Eur J Immunol       Date:  2001-03       Impact factor: 5.532

4.  Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation.

Authors:  Y Xiong; M A Luscher; J D Altman; M Hulsey; H L Robinson; M Ostrowski; B H Barber; K S MacDonald
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.

Authors:  P Shankar; M Russo; B Harnisch; M Patterson; P Skolnik; J Lieberman
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

6.  In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.

Authors:  M T Puglielli; A J Zajac; R G van der Most; J L Dzuris; A Sette; J D Altman; R Ahmed
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

7.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Functional impairment of simian immunodeficiency virus-specific CD8+ T cells during the chronic phase of infection.

Authors:  T U Vogel; T M Allen; J D Altman; D I Watkins
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

9.  Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children.

Authors:  P J Goulder; Y Tang; C Brander; M R Betts; M Altfeld; K Annamalai; A Trocha; S He; E S Rosenberg; G Ogg; C A O'Callaghan; S A Kalams; R E McKinney; K Mayer; R A Koup; S I Pelton; S K Burchett; K McIntosh; B D Walker
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

Review 10.  Assessing CD8 T cell number and dysfunction in the presence of antigen.

Authors:  R M Welsh
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

View more
  79 in total

1.  Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.

Authors:  Joseph A Conrad; Ramesh K Ramalingam; Coley B Duncan; Rita M Smith; Jie Wei; Louise Barnett; Brenna C Simons; Shelly L Lorey; Spyros A Kalams
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

2.  Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery.

Authors:  Shaobo Han; Ayuna Asoyan; Hannah Rabenstein; Naoko Nakano; Reinhard Obst
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

3.  Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression.

Authors:  Andreas Bergthaler; Lukas Flatz; Ahmed N Hegazy; Susan Johnson; Edit Horvath; Max Löhning; Daniel D Pinschewer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

4.  Antigen specific killing assay using CFSE labeled target cells.

Authors:  Marina Durward; Jerome Harms; Gary Splitter
Journal:  J Vis Exp       Date:  2010-11-09       Impact factor: 1.355

5.  Pronounced virus-dependent activation drives exhaustion but sustains IFN-γ transcript levels.

Authors:  Kathryn J Mackerness; Maureen A Cox; Lauren M Lilly; Casey T Weaver; Laurie E Harrington; Allan J Zajac
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

6.  ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation.

Authors:  Nicholas A Zumwalde; Eisuke Domae; Matthew F Mescher; Yoji Shimizu
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

Review 7.  Biomarkers for glioma immunotherapy: the next generation.

Authors:  Jennifer S Sims; Timothy H Ung; Justin A Neira; Peter Canoll; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2015-02-28       Impact factor: 4.130

Review 8.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

Review 9.  Manipulating the PD-1 pathway to improve immunity.

Authors:  Alice O Kamphorst; Rafi Ahmed
Journal:  Curr Opin Immunol       Date:  2013-04-09       Impact factor: 7.486

10.  Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution.

Authors:  Victoria Kasprowicz; Yu-Hoi Kang; Michaela Lucas; Julian Schulze zur Wiesch; Thomas Kuntzen; Vicki Fleming; Brian E Nolan; Steven Longworth; Andrew Berical; Bertram Bengsch; Robert Thimme; Lia Lewis-Ximenez; Todd M Allen; Arthur Y Kim; Paul Klenerman; Georg M Lauer
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.